Growth Hormone Secretagogue MK-0677's Effect on Lean Body Mass in Chronic Kidney Disease Stage 4/5 Subjects
|ClinicalTrials.gov Identifier: NCT01343641|
Recruitment Status : Withdrawn (Could not obtain drug supply from manufacturer)
First Posted : April 28, 2011
Last Update Posted : May 14, 2018
University of Virginia
National Institutes of Health (NIH)
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Warren K Bolton, University of Virginia
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Recruitment Status :||Withdrawn|
|Actual Primary Completion Date :||April 2010|
|Actual Study Completion Date :||April 2010|